HAIFA, Israel , August 13 /PRNewswire/ -- SCD has announced the receipt of a phase I contract from DARPA, valued at $1.75 million, for the development of a new "XBn" infrared detector technology. If ...
TipRanks on MSN
Seastar Medical’s Innovative Approach to Treating Severe Heart Failure: A Study Update
Seastar Medical Holding Corporation (($ICU)) announced an update on their ongoing clinical study. Seastar Medical Holding Corporation (ICU) is ...
DENVER, April 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients ...
SeaStar Medical Holding Corporation (NASDAQ:ICU) shares are trading higher on Thursday, on continued strength after the company received FDA Breakthrough Device Designation for its cell-directed ...
TipRanks on MSN
Seastar Medical’s QUELIMMUNE Study: A Potential Game Changer for Pediatric AKI Treatment
Seastar Medical Holding Corporation (($ICU)) announced an update on their ongoing clinical study. Seastar Medical Holding Corporation is ...
DENVER, Oct. 18, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation ...
SeaStar Medical (NASDAQ:ICU) said it has received an Approvable Letter from the FDA for its Selective Cytopheretic Device Pediatric, or SCD-PED, for use in children with acute kidney injury and sepsis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback